Brown, Lisle/cummings »

Silverback Therapeutics shares owned by Brown, Lisle/cummings

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Brown, Lisle/cummings from 13F filings

Historical chart of Brown, Lisle/cummings investment in Silverback Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 29450050005500399399.5400400.5401
Value ($)Share countHistorical SPRY position of Brown, Lisle/cummings Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Brown, Lisle/cummings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Brown, Lisle/cummings

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.2k 400 10.55
2024-09-30 $5.8k 400 14.50

More positions owned by Brown, Lisle/cummings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Intercontinental Exchange (ICE)
Accenture Plc Ireland Shs Class A (ACN)
Boston Scientific Corporation (BSX)
Amgen (AMGN)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Abbvie (ABBV)
Meta Platforms Cl A (META)
Canadian Natl Ry (CNI)
Fiserv (FI)

View all positions for Brown, Lisle/cummings

Top funds holding Silverback Therapeutics

RA Capital Management
Deerfield Management Company
OrbiMed Advisors
BlackRock
Sr One Capital Management
Alliancebernstein
Vanguard Group
State Street Corporation
Franklin Resources
Alyeska Investment Group
Geode Capital Management
Woodline Partners
Nextech Invest
FMR
Citadel Advisors

View all funds holding Silverback Therapeutics